https://auntresodamid.com/iJugHxINePLH1VY/96561

Breaking news

Intel working with bankers to present board with strategic options

Intel working with bankers to present board with strategic options

Technology News

Pat Gelsinger, CEO Intel, speaking on CNBC’s Squawk Box at the WEF Annual Meeting in Davos, Switzerland on Jan. 16th, 2024. Adam Galici | CNBC Intel executives are working with multiple advisors to formulate options to address its flagging business, according to a person with knowledge of the matter. Those advisors, which include Morgan Stanley and […]

Intel working with bankers to present board with strategic options Read More »

FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days

FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days

Business News

The Food and Drug Administration on Thursday approved updated Covid vaccines from Pfizer and Moderna, putting the new shots on track to reach most Americans in the coming days amid a summer surge of the virus.  The jabs target a strain called KP.2, a descendant of the highly contagious omicron subvariant JN.1 that began circulating

FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days Read More »

Health-care system Sesame to offer compounded versions of Wegovy through new 9 weight loss program

Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program

Business News

Health-care marketplace Sesame on Wednesday announced a new clinical weight loss program that will help eligible consumers access compounded versions of Novo Nordisk‘s blockbuster obesity drug Wegovy for $249 per month. Sesame allows patients to book and pay for appointments with doctors and specialists directly through its website, so it cuts out middlemen such as

Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program Read More »

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

Business News

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.  Shelby Knowles | Bloomberg | Getty Images Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial Read More »

Here’s why Walgreens and CVS retail pharmacies are struggling — and what they’re doing to fix it

Here’s why Walgreens and CVS retail pharmacies are struggling — and what they’re doing to fix it

Business News

The abundance of Walgreens and CVS Health stores makes them convenient for whenever Shriya Raghavan, a research associate based in Philadelphia, needs to pick up necessities like gum, deodorant and soap.  But she said she often has to wait for employees to unlock cabinets or stand in lengthy lines to pick up prescriptions as pharmacists

Here’s why Walgreens and CVS retail pharmacies are struggling — and what they’re doing to fix it Read More »

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

Business News

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations Read More »

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

Business News

Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s.  Most insurance plans cover GLP-1s when they are used to treat diabetes, so those patients can usually avoid the roughly

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs Read More »

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

Business News

Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike. Shares of Eli Lilly jumped more than 11% in premarket trading Thursday. The drugmaker now expects revenue for the

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar Read More »

Trump’s tech backers are ‘making a big mistake,’ Sequoia’s Mike Moritz says

Trump’s tech backers are ‘making a big mistake,’ Sequoia’s Mike Moritz says

Technology News

Michael Moritz, Sequoia Capital Scott Mlyn | CNBC As leading tech investors continue to vocally take sides ahead of the 2024 presidential election, legendary venture capitalist Michael Moritz is making his preference clear. In a Financial Times opinion piece published on Monday, Moritz wrote that those in the industry who are supporting Donald Trump “are

Trump’s tech backers are ‘making a big mistake,’ Sequoia’s Mike Moritz says Read More »

Stay Connected

Facebook-f Reddit Pinterest

Subscribe

Subscribe
Subscribe

Don’t miss latest news!

Select list(s):

We don’t spam! Read our [link]privacy policy[/link] for more info.

Scroll to Top